Here's what to do...
Stansberry Research

Dear Reader,

You forgot to claim your bonus last night.

Remember – you can claim a full bonus year of Retirement Millionaire… which could have a huge impact on your wealth.

It's part of an opportunity we've waited 17 years for.

Last night we held a live briefing to talk about it… a breakthrough that could help save the retirement of millions of people around the world.

In case you missed it…

Beginning Dec. 31st, one little-known company could receive worldwide approval for a new medical treatment that will successfully treat 50% of patients with the worst disease faced by U.S. seniors and retirees.

The stock could soar 200% once approval comes through. Three times your money… on a single investment right now.

We're sharing the full details in Venture Technology, our most elite product.

If you're interested, here's what to do…

Simply call our office today at 800-961-5843, and we'll credit you with 2 full years of access to Venture Technology… for nearly 50% off the normal price.

Normally, this would cost you $11,000.

If you call us today, you'll receive access for 2 full years… for nearly HALF OFF that amount, one of the best offers we'll ever make.

** Plus, you'll receive a full bonus year of Retirement Millionaire, which normally costs $199 a year.**

More importantly, we urge you to buy our #1 Venture pick right now.

Beginning December 31st, we expect the stock could soar hundreds of percent when the company receives FDA approval.

You can read about it here.

Regards,

Mike Cottet
Director of Member Services
Stansberry Research

P.S. Did you miss our live briefing last night?

If so, give us a call today at 800-961-5843 and we'll give you a quick recap – including the details of our #1 biotech recommendation, which we urge you to buy before approval comes through beginning Dec. 31.

Once approval comes through, the stock could realistically double overnight. Now is the best time to get in, if you're interested.



All contents of this e-mail are copyright 2017 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.

DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.

You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to info@stansberrycustomerservice.com.

To unsubscribe from this mailing, click here: Unsubscribe